A landmark study reveals how Kupffer cells, resident macrophages of the liver, can promote antitumor immunity. Central to this function is ID3, a Kupffer cell lineage-determining factor. The findings provide new insights into cancer therapy.
References
Deng, Z. et al. Nature https://doi.org/10.1038/s41586-023-06950-4 (2024).
Cassetta, L. & Pollard, J. W. Nat. Rev. Cancer 23, 238–257 (2023).
Pittet, M. J., Michielin, O. & Migliorini, D. Nat. Rev. Clin. Oncol. 19, 402–421 (2022).
Hanahan, D. Cancer Discov. 12, 31–46 (2022).
Binnewies, M. et al. Nat. Med. 24, 541–550 (2018).
Franklin, R. A. et al. Science 344, 921–925 (2014).
Zhu, Y. et al. Immunity 47, 323–338.e6 (2017).
Casanova-Acebes, M. et al. Nature 595, 578–584 (2021).
Nalio Ramos, R. et al. Cell 185, 1189–1207.e25 (2022).
Paget, S. Lancet 133, 571–573 (1889).
Siwicki, M. et al. Sci. Immunol. 6, eabi7083 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.J.P. has served as a consultant for AstraZeneca, Elstar Therapeutics, ImmuneOncia, KSQ Therapeutics, LegoChem Bio, Merck, Siamab Therapeutics, Third Rock Ventures, Tidal and Unikum.
Rights and permissions
About this article
Cite this article
Goubet, AG., Pittet, M.J. Unveiling the antitumor function of ID3 in liver macrophages. Nat Immunol 25, 394–395 (2024). https://doi.org/10.1038/s41590-024-01761-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-024-01761-9
- Springer Nature America, Inc.